- Quasim M, Kumar A (1999) Recent advances in antidepressant drug therapy. Int J Psych Gin Pract 3: 17-22.
- Murphy DL, Mitchell PB, Potter WZ (1995) Novel pharmacological approaches to the treatment of depression. In Psychopharmacology: The fourth generation of progress (eds FE Bloom, DJ Kupfer) 1143-54. Raven Press, New York
- Thiebot MH, Martin P, Puech AJ (1992) Animal behavioral studies in the evaluation of antidepressant drugs. BrJ Psychiatry 15: 44-50.
- Potter WZ, Demitrack MA, DeBrota DJ et al (1998) Controlling the placebo response rates in depression. Eur Neuropsychopharmacol 8 (Suppl 2): S80.
- Sennef C, Finder RM, Reimitz PE, Niklson IA (1998) Investigator influence on drug-placebo differences in depression. Eur Newopsychopharmacol 8 (Suppl 2): S80.
- Lovenberg TW, Baron BM, de Lecea L et al (1993) A novel adenylyl cyclase-activating serotonin receptor (5-HT7) implicated in the regulation of mammalian circadian rhythms. Neuron 11: 449-58.
- Manama FJ Jr, Shen Y, Ward RP et al (1993) Cloning and expression of a novel serotonin receptor with high affinity for tricyclic psychotropic drugs. MoI Pharmacol 43: 320-7.
- Robertson DW, Fuller RW (1991) Progress in antidepressant drugs. Annu Rep Med Chem 3: 23-31
- Wong DT, Bymaster FP, Reid LR et al (1993) Norfluoxetine enantiomers as inhibitors of serotonin uptake in rat brain. Neuropsychopharmacd 8: 337-44.
- Stevens JC, Wrighton SA (1993) Interaction of the enantiomers of fluoxetine and norfluoxetine human liver cytochromes P450. J Pharmacol Exp Ther 266: 964-71.
- Hyttel J, Bageso KP, Perregaard J, Sánchez C (1992) The pharmacological effect of citalopram resides in the (S) - (+)enantiomer. J Neural Transm 88: 157-60.
- Blier P (1998) Neurobiological basis for the potentiation of antidepressant treatments by pindolol. Eur Neuropschycopharmacol 8 (Supp12): S96.
- McAskill R, Mir S, Taylor D (1998) Pindobl augmentation of antkiepressant therapy. Br J Psychiatry 173: 203-8.
- Artigas F (1998) Pindolol augmentation: Single or multiple targets in the brain? Eur Neuropsychopharmacd 8 (Suppl 2): S97.
- Zanardi R, Franchini L, Gasperini M et al (1998) Selective serotonin reuptake inhibitors alone and in association with pindolol in the treatment of delusional depression. Eur Neuropsychopharmacd 8 (Suppl 2): S98.
- Saleh S, Johnstron A, Turner P (1990) Absolute bioavailability and pharmacokinetics of medifoxamine in healthy humans. Br J Clin Pharmacol 30: 621-4.
- Vinar O, Klein DF, Potter WZ, Cause EM (1991) Survey of psychotropic medications not available in the United States. Neuropsychopharmacd 5: 201-17.
- Standish-Barry HM, Bouras N, Bridges PK Watson JP (1983) A randomized double blind group comparative study of sulphide and amitriptyline in affective disorder. Psychopharmacol (Berl.) 81: 258-60.
- Tolkfson GD, Sanger TM, Lu Y, Thieme ME (1998) Depressive signs and symptoms in schizophrenia: A prospective blinded trial of olanzapine and haloperidol. Arch Gen Psychiatry 55: 250-8.
- Maj J, Rogóz Z, Skuza G et al (1997) Antidepressant effects of pramipexole, a novel dopamine receptor agonist. J Neural Transm 104: 525-33.
- Kramer MS, Cutler N, Feighner J et al (1998). Distinct mechanism for antidepressant activity by blockade of central substance P receptors. Science 281: 1640-5.
- Feighner JP (1998) Substance P. Eur Neuropsychopharmacd 8 (Suppl 2): S85.
- Gray AM, Spencer PS, Sewell RD (1998) The involvement of the opioidergjc system in the antinociceptive mechanism of action of antidepressant compounds. Br J Pharmacol 124: 669-74.
- Kita A, Imano K, Seto Y et al (1997) Antinociceptive and antidepressant-like profiles of BL-2401, a novel enkephalinase inhibitor, in mice and rats. Jpn J Pharmacol 75: 337-46.
- Smadja C, Ruiz F, Coric P et al (1997) CCK-B receptors in the limbic system modulate the antidepressant-like effects induced by endogenous enkephalins. Psychopharmacol (Ben) 132: 227-36.
- Overstreet DH, Pucilowski O, Return MC et al (1998) Effects of melatonin receptor ligands on swim test immobility. Neuroreport 9: 249-53.
- Dalian FJ, Rotondi D, Levitan RD et al (2000) Use of slowrelease melatonin in treatment-resistant depression. J Psychiatry Neurosci 25: 48-51
- Lewy AJ, Bauer VK, Cutler NL, Sack RL (1998) Melatonin treatment of winter depression: a pilot study. Psychiatry Res 77: 57-61.
- Eison AS, Freeman RP, Guss VB et al (1995) Melatonin antagonists modulate 5HT2A receptor mediated neurotransmission: behavioural and biochemical studies in the rat J Pharmacol Exp Ther 273: 304-8.
- Duman RS (1998) Novel therapeutic approaches beyond the serotonin receptor. Biol Psychiatry 44: 324-35.
- Maeda H, Ozawa H, Salto T et al (1997) Potential antidepressant properties of forskolin and a novel water-soluble forskolin (NKH477) in forced swimming test Life Sci 61: 2435-42.
- Scott AIF, Perini AF, Shering PA, Whalley F (1991) In-patient major depression: is rolipram as effective as amitriptyline? Eur J Clin Pharmacol 40: 127-9.
- Ahn DK, Kim YS, Park JS (1998) Central NO is involved in the antinociceptive action of intracisternal antidepressants in freely moving rats. Neurosci Lett 243: 105-8.
- Eroglu L, Caglayan B (1997) Anxiolytic and antidepressant properties of methylene blue in animal models. Pharmacol Res 36: 381-5.
- Ballard SA, Gingell CJ, Tang K et al (1998) Effects of sildenafil on the relaxation of human corpus cavernosum tissue in vitro and on the activities of cyclic nucleotide phosphodiesterase isozymes. J Urol 159: 2164-71.
- Boolell M, Men MJ, Ballard SA et al (1996) Sildenafil: an orally active type 5 cyclic GMP specific phosphodiesterase inhibitor for the treatment of penile erectile dysfunction. Int J Impotence Res 8: 47-52.
- Shen WW, Urosevich Z, Clayton DO (1999) Sildenafil in the treatment of female sexual dysfunction induced by selective serotonin reuptake inhibitors. J Reprod Med 44: 535-41
- Fava M, Rankin M, Alpert JE et al (1998) An open trial of oral sildenaffl in antidepressant induced sexual dysfunction. Psychother Psychosom 67: 328-31.
- Berk M, Wadee AA, Kusdike RH, O'Neill-Kerr AJ (1997) Acute phase proteins in major depression. J Psychosom Res 43: 52934.
- Hellstrand K and Hermodsson S (1987) Role of serotonin in the regulation of natural killer cell activity. J Immunol 139: 869-75.
- Niiranen A, Laaksonen R, Iivanainen M et al (1988) Behavioral assessment of patients treated with alpha-interferon. Acta Psychiatr Scand 78: 622-6.
- Lishman WA (1987) Organic Psychiatry: The psychological consequences of cerebral disorder. Blackwell Scientific, Oxford.
- Grossman CJ (1985) Interactions between the gonadal steroids and the immune system. Science 227: 257-61.
- Xia Z, DePierre JW, Nässberger L (1996) Tricyclic antidepressants inhibit IL-6, IL-1 beta and TNF-alpha release in human blood monocytes and IL-2 and interferon-gamma in T cells. Immunopharmacology 34: 27-37.
- Shintani F, Nakaki T, Kanba S et al (1995) Involvement of interleukin-1 in immobilization stress-induced increase in plasma adrenocorticotropic hormone and in release of hypothalamic monoamines in the rat J Neurosci 15: 1961-70.
- Connor TJ, Leonard BE (1998) Depression, stress and immunological activation: the role of cytokines in depressive disorders. Life Sci 62: 583-606.
- Cohen BM, Zubenko GS (1988) Captopril in the treatment of recurrent major depression. J Clin Psychopharmacol 8: 143-4.
- Martin P, Massol J, Peuch AJ (1990) Captopril as an antidepressant? Effects on the learned helplessness paradigm in rats. Biol Psychiatry 27: 968-74.
- Murphy BEP, Dhar V, Ghadirian AM et al (1991) Response to steroid suppression in major depression resistant to antidepressant therapy. J Clin Psychopharmacol 11: 121-6.
- Wolkowitz OM, Reus VI, Manfredi F et al (1993) Ketoconazole administration in hypercortisolemic depression. Am J Psychiatry 150: 810-2.
- Mansbach RS, Brooks EN, Chen YL (1997) Antidepressant-like effects of CP-154,526, a selective CRF1 receptor antagonist Eur J Pharmacol 323: 21-6.
- Berk M, Plein H Belsham B (2000) The specificity of platelet glutamate receptor supersensitivity in psychotic disorders, life Sci 66: 2427-31
- Maj J, Rogoz Z, Skusa G, Sowinska H (1992) Effects of MK-801 and antidepressant drugs in the forced swimming test in rats. Eur Neuropsychopharmacd 2: 37-41.
- Trullas R, Skolnick P (1990) Functional antagonists at the NMDA receptor complex exhibit antidepressant actions. Eur J Pharmacol 185: 1-10.
- Javitt DC, Zukin SR (1991) The role of excitatory amino acids in neuropsychiatrie illness. Am J Psychiatry 148: 1301-8.
- Berk M, Plein H, Ferreira D, Jersky B (2000) Platelet adenosine A2A receptor subsensitivity in major depressive disorder. Presented at the 22 Congress of the Collegium Internationale Neuro-Psychopharmacologicum, Brussels.
- Williams M (1989) Adenosine: the prototypic neuromodulator. Neurochem Inter 14: 249-64.
- Williams M (1995) Purinoceptors in central nervous system function. Targets for therapeutic intervention. In Psychopharmacology: The fourth generation of progress (eds FE Bloom, DJ Kupfer) 643-56. Raven Press, New York
- Siuciak JA, Lewis DR, Wiegand SJ, Lindsay RM (1997) Antidepressant-like effect of brain-derived neurotrophic factor (BDNF). Pharmacol Biochem Behav 56: 131-7.
- Altar CA (1999) Neurotrophins and depression. Trends Pharmacol Sci 20: 59-61.
- Bennett DA Jr, Phun L, Polk JF et al (1998) Neuropharmacology of St. John's wort (Hypericum). Ann Pharmacother 32: 1201-8.
- Müller WE, Rolli M, Schafer C, Hafner U (1997) Effects of hypericum extract (LI 160) in biochemical models of antidepressant activity. Pharmacapsychiatry 30 (suppl 2): 102-7.
- Neary JT, Bu Y (1999) Hypericum LI 160 inhibits uptake of serotonin and norepinephrine in astrocytes. Brain Res 816: 358-63.
- Raffe RB (1998) Screen of receptor and uptake-site activity of hypericin component of St John's wort reveals Sigma receptor binding. Life Sci 62: 265-70.
- Linde K, Ramirez G, Mulrow CD et al (1996) St John's wort for depression -- an overview and meta-analysis of randomised clinical trials. Br Med J 313: 253-8.
- Linde K Berner M (1999) Has hypericum found its place in antidepressant treatment? Br Med] 319: 1539.
- Massot O, Grimaldi B, Bailly JM et al (1998) Magnetic field (MF) affects 5-HT1B receptor function in brain: Molecular and cellular studies. Eur Neuropsychopharmacol 8 (Suppl 2): S119.
- Belmaker RH, Grisaru N (1998) Transcranial magnetic stimulation in mania. Eur Neuropsychapharmacol 8 (Suppl 2): S120.
- Schlapfer T E, Rupp F, Fisch HU, Hess CW (1998) Effect of rTMS and ECT on gene expression: Same or different antidepressant mechanisms? Eur Neuropsychapharmacd 8 (Suppl 2): S121.
- George MS, Bohning DE, Nahas Z et al (1998) Functional neuroimaging studies of TMS: SPECT, PET and fMRJ. Eur Neurapsychopharmacd 8 (Suppl 2): S122.
- Pascual-Leone A, Keenan J, Freund S et al (1998) Repetitive transcranial magnetic stimulation trials in depression. Eur Neurapsychopharmacd 8 (Suppl 2): S123.
- Klein E, Kreinin I, Chistyakov A et al (1999) Therapeutic efficacy of right prefrontal slow repetitive transcranial magnetic stimulation in major depression: a double-blind controlled study. Arch Gen Psychiatry 36: 315-20.
International Journal of Psychiatry in Clinical Practice
Volume 4, 2000 - Issue 4